Cansortium Stock Analysis
| CNTMF Stock | USD 0.08 0 2.35% |
Cansortium is overvalued with Real Value of 0.0797 and Hype Value of 0.08. The main objective of Cansortium otc analysis is to determine its intrinsic value, which is an estimate of what Cansortium is worth, separate from its market price. There are two main types of Cansortium's stock analysis: fundamental analysis and technical analysis.
The Cansortium otc stock is traded in the USA on OTCQX Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Cansortium's ongoing operational relationships across important fundamental and technical indicators.
Cansortium |
Cansortium OTC Stock Analysis Notes
About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.96. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cansortium recorded a loss per share of 0.1. The entity had not issued any dividends in recent years. Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida. Cansortium operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Cansortium is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Cansortium please contact Robert Beasley at 305 902 2720 or go to https://www.getfluent.com.Cansortium Investment Alerts
| Cansortium generated a negative expected return over the last 90 days | |
| Cansortium has high historical volatility and very poor performance | |
| Cansortium has some characteristics of a very speculative penny stock | |
| Cansortium has high likelihood to experience some financial distress in the next 2 years | |
| Cansortium has accumulated 53.67 M in total debt with debt to equity ratio (D/E) of 1.89, which is about average as compared to similar companies. Cansortium has a current ratio of 0.72, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Cansortium until it has trouble settling it off, either with new capital or with free cash flow. So, Cansortium's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cansortium sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cansortium to invest in growth at high rates of return. When we think about Cansortium's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 65.44 M. Net Loss for the year was (19.04 M) with profit before overhead, payroll, taxes, and interest of 35.79 M. | |
| Cansortium has accumulated about 8.86 M in cash with (5.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Roughly 21.0% of Cansortium shares are held by company insiders |
Cansortium Thematic Classifications
In addition to having Cansortium otc stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Soft DrinksSoft drinks beverages and refreshments |
Cansortium Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 33.24 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cansortium's market, we take the total number of its shares issued and multiply it by Cansortium's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Cansortium Profitablity
Cansortium's profitability indicators refer to fundamental financial ratios that showcase Cansortium's ability to generate income relative to its revenue or operating costs. If, let's say, Cansortium is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Cansortium's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Cansortium's profitability requires more research than a typical breakdown of Cansortium's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.29) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08. Technical Drivers
As of the 27th of November, Cansortium shows the Standard Deviation of 7.75, risk adjusted performance of (0.05), and Mean Deviation of 5.16. Cansortium technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have collected data for thirteen technical drivers for Cansortium, which can be compared to its peers. Please confirm Cansortium variance and value at risk to decide if Cansortium is priced correctly, providing market reflects its regular price of 0.083 per share. As Cansortium appears to be a penny stock we also recommend to validate its jensen alpha numbers.Cansortium Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Cansortium middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Cansortium. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Cansortium Outstanding Bonds
Cansortium issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cansortium uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cansortium bonds can be classified according to their maturity, which is the date when Cansortium has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Cansortium Predictive Daily Indicators
Cansortium intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cansortium otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 0.083 | |||
| Day Typical Price | 0.083 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0) |
Cansortium Forecast Models
Cansortium's time-series forecasting models are one of many Cansortium's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cansortium's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Cansortium OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Cansortium prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cansortium shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Cansortium. By using and applying Cansortium OTC Stock analysis, traders can create a robust methodology for identifying Cansortium entry and exit points for their positions.
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida. Cansortium operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Cansortium to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Complementary Tools for Cansortium OTC Stock analysis
When running Cansortium's price analysis, check to measure Cansortium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cansortium is operating at the current time. Most of Cansortium's value examination focuses on studying past and present price action to predict the probability of Cansortium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cansortium's price. Additionally, you may evaluate how the addition of Cansortium to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |